Clinical Scorecard: Gastric Glomus Tumor: A Case Study with Imaging Findings
At a Glance
Category
Detail
Condition
Gastric Glomus Tumor (GT)
Key Mechanisms
Benign neoplasm arising from glomus apparatus vascular components; characterized by uniform epithelioid cells positive for smooth muscle actin
Target Population
Patients with gastric submucosal masses, commonly in the antrum, typically middle-aged to elderly adults
Care Setting
Gastroenterology and surgical units with access to endoscopic ultrasound and laparoscopic surgery
Key Highlights
GTs are rare benign tumors of the stomach, often located in the antrum and measuring 2–2.5 cm.
EUS-FNA with cytopathology and immunohistochemistry (positive for smooth muscle actin, negative for desmin, cytokeratin, and other markers) is critical for accurate diagnosis.
Laparoscopic wedge resection is an effective minimally invasive treatment with good prognosis and low morbidity.
Guideline-Based Recommendations
Diagnosis
Use endoscopic ultrasound (EUS) to identify submucosal gastric lesions.
Perform EUS-guided fine needle aspiration (EUS-FNA) with on-site cytopathology for cytological diagnosis.
Confirm diagnosis with immunohistochemical staining showing positivity for smooth muscle actin and negativity for desmin, cytokeratin, CD117, CD34, and other markers.
Management
Complete surgical removal of the tumor via laparoscopic wedge resection is recommended.
Consider subtotal gastrectomy if indicated by tumor size or location.
No established guidelines exist; treatment decisions should consider benign nature and absence of malignancy features.
Monitoring & Follow-up
Postoperative follow-up to ensure surgical margins are free of disease.
Monitor for recurrence clinically and with imaging as needed.
Risks
Potential misdiagnosis as gastrointestinal stromal tumor (GIST) or gastric cancer.
Risk of gastrointestinal bleeding presenting as hematemesis or melena.
Surgical risks associated with laparoscopic resection.
Patient & Prescribing Data
Elderly patients presenting with incidental or symptomatic gastric submucosal masses
Minimally invasive laparoscopic wedge resection allows early discharge and good recovery; EUS-FNA aids in avoiding overtreatment of benign lesions.
Clinical Best Practices
Utilize EUS-FNA with immunohistochemical analysis for accurate preoperative diagnosis.
Prefer laparoscopic wedge resection for small, benign gastric glomus tumors to minimize morbidity.
Ensure surgical margins are clear to reduce risk of recurrence.
Differentiate GTs from other gastric tumors using immunohistochemical markers to guide appropriate management.
